FDAnews
www.fdanews.com/articles/98201-patch-problem-forces-withdrawal-of-adhd-treatment

Patch Problem Forces Withdrawal of ADHD Treatment

September 7, 2007

Shire voluntarily withdrew a limited number its Daytrana patches for attention deficit hyperactivity disorder because of reported difficulties removing the release liner off the patches.
Philadelphia Business Journal